Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue 7, 2005, Pages 647-653

  Ho, Andrew T ^a   Pai, Sudha M ^a   Timothy, Pam ^a   Pai, Ramdas G ^b  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antiarrhythmic therapy; Defibrillator; ICD; Survival

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SOTALOL; STATINE DERIVATIVE; WARFARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; DIABETES MELLITUS; DRUG EFFECT; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; HYPERTENSION; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY PREVENTION; RISK ASSESSMENT; SECONDARY PREVENTION; SIDE EFFECT; SUDDEN DEATH; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; COMBINED MODALITY THERAPY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DIGOXIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SOTALOL; STROKE VOLUME; SURVIVAL RATE;

EID: 22244436653     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.00164.x     Document Type: Article

References (10)

1. Bigger T. Expanding indications for implantable cardiac defibrillators. N Engl J Med 2002; 346(12):931-933.
2. Moss J. Improved survival with an implanted defibrillator in patients with coronary disease at high risk of ventricular arrhythmias. N Engl J Med 1996; 335(26):1933-1940.
3. Moss J. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346(12):877-883.
4. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythraic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337(22):1576-1583.
5. AVID Investigators. Causes of death in the antiarrhythmics versus implantable defibrillators (AVID) trial. J Am Coll Cardiol 1999; 34(5):1552-1559.
6. Buxton A. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999: 341(25):1882-1890.
7. Marchlinski FE. Concomitant device and drug therapy: Current trends, potential benefits, and adverse interactions. Am J Cardiol 1999; 84(9A):69-75.
8. Santini M. Combining antiarrhythmic drugs and implantable devices therapy: Benefits and outcome. J Intervent Cardiol Electrophysiol 2000; 4(1):65-89.
9. Kroll RB, Saksena S, Prakash A. Interactions of antiarrhythmic drugs with implantable defibrillator therapy for atrial and ventricular tachyarrhythmias. Curr Cardiol Rep 1999; 1(4):282-288.
10. Schiller NB, Shah PM. Recommendations for quantitation of left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1998; 2:358-367.